Evidence map›Paper›PMID 29932850›Full record

ReviewHuman vaccines & immunotherapeutics2018

Public health responses during measles outbreaks in elimination settings: Strategies and challenges.

Paul A Gastañaduy, Emily Banerjee, Chas DeBolt, Pamela Bravo-Alcántara, Samia A Samad, Desiree Pastor, Paul A Rota, Manisha Patel, Natasha S Crowcroft, David N Durrheim

Abstract readReview
In one paragraph

Review in Human vaccines & immunotherapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Informing quarantine policy for measles control in primary school and daycare settings: insights from a simulation study, Flanders, Belgium.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  6. Article
  7. The health and economic repercussions of declining MMR coverage in the United States.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paul A Gastañaduya Division of Viral Diseases, Centers for Disease Control and Prevention , Atlanta , GA , USA.
Emily Banerjeeb Vaccine Preventable Disease Surveillance Unit , Minnesota Department of Health , St. Paul , MN , USA.
Chas DeBoltc Vaccine-Preventable Diseases , Washington State Department of Health , Shoreline , WA , USA.
Pamela Bravo-Alcántarad Comprehensive Family Immunization Unit, Pan American Health Organization , Washington , DC , USA.
Samia A Samade Pan American Health Organization , Lima , Perú.
Desiree Pastord Comprehensive Family Immunization Unit, Pan American Health Organization , Washington , DC , USA.
Paul A Rotaa Division of Viral Diseases, Centers for Disease Control and Prevention , Atlanta , GA , USA.
Manisha Patela Division of Viral Diseases, Centers for Disease Control and Prevention , Atlanta , GA , USA.
Natasha S Crowcroftf Public Health Ontario , Toronto , ON , Canada ; Dalla Lana School of Public Health, University of Toronto , Toronto , ON , Canada.
David N Durrheimg School of Medicine and Public Health, University of Newcastle , Newcastle , New South Wales , Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In late September 2016, the Americas became the first region in the world to have eliminated endemic transmission of measles virus. Several other countries have also verified measles elimination, and countries in all six World Health Organization regions have adopted measles elimination goals. The public health strategies used to respond to measles outbreaks in elimination settings are thus becoming relevant to more countries. This review highlights the strategies used to limit measles spread in elimination settings: (1) assembly of an outbreak control committee; (2) isolation of measles cases while infectious; (3) exclusion and quarantining of individuals without evidence of immunity; (4) vaccination of susceptible individuals; (5) use of immunoglobulin to prevent measles in exposed susceptible high-risk persons; (6) and maintaining laboratory proficiency for confirmation of measles. Deciding on the extent of containment efforts should be based on the expected benefit of reactive interventions, balanced against the logistical challenges in implementing them.

Indexed as

Disease EradicationDisease OutbreaksAmericasCommunicable Disease ControlDisease Transmission, InfectiousHumansMeaslesControl measureseliminationimmunoglobulinmeaslesoutbreakssocial distancingvaccine

Identifiers

PMID29932850
PMCPMC6207419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.